TP-MOTIVA

What this means for you

Not registered yet, but its 15 Sept 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

50109353

Mark type

Stylized text

Filed

15 Sept 2026

Attorney of record

Jonathan P. Soifer

Goods and services

• Class 009 — Scientific and electric apparatus: Downloadable software using artificial intelligence (AI) for drug formulation development; downloadable software using artificial intelligence (AI) for monitoring, tracking, analysing and generating information in the field of drug development, drug development trials and medical device trials; AI-based software with generative and analytical AI models for monitoring, tracking, analysing and generating information in the field of drug development, drug development trials and medical device trials; downloadable collaboration software platforms for monitoring, tracking, analysing and generating information in the field of drug development, drug development trials and medical device trials; computer software for monitoring, tracking, analysing and generating information in the field of drug development trials and medical device trials; computer software for use in the field of biological research modelling; computer software adapted for use in medical device and pharmaceutical development studies; computer software designed to assist in the selection of patients and sites for use in clinical trials; computer software for financial and insurance purposes in the fields of pharmaceuticals and medical devices; electronic publications including books, pamphlets, articles, technical manuals, instruction and teaching materials and reports distributed in an electronic medium in the field of drug development, drug development trials and medical device trials
• Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals and biopharmaceuticals; custom manufacture of pharmaceuticals and biopharmaceuticals for clinical trial purposes; manufacturing services for clinical trials, namely manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; providing information about the results of clinical trials for pharmaceutical and biopharmaceutical products, namely providing technical information in the field of pharmaceutical and biopharmaceutical manufacturing
• Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring software using artificial intelligence (AI) for drug formulation development; software as a service (SAAS) services featuring software using artificial intelligence (AI) for monitoring, tracking, analysing and generating information in the field of drug development, drug development trials and medical device trials; software as a service (SAAS) services for monitoring, tracking, analysing and generating information in the field of drug development, drug development trials and medical device trials; clinical research in the field of pharmacology and medical research; clinical trials for others; conducting clinical trials for others; conducting clinical trials for others in the field of pharmaceutical and biopharmaceutical products; pharmaceutical and biopharmaceutical research services; pharmaceutical and biopharmaceutical testing services; research relating to science namely, scientific research, basic and clinical research in the fields of pharmacology, pharmaceuticals and biopharmaceuticals; analytical services, namely, evaluation and analysis of the efficacy of pharmaceutical and biopharmaceutical products and dosages in the nature of analysis and evaluation of pharmaceutical and biopharmaceutical products and dosages of others to determine conformity with certification standards and to assure compliance with industry standards; pharmaceutical and biopharmaceutical product evaluation; providing medical and scientific research information in the field of pharmaceuticals, biopharmaceuticals and clinical trials; providing medical and scientific research information in the field of pharmaceuticals, biopharmaceuticals and clinical trials in the nature of information regarding testing of pharmaceutical and biopharmaceutical products; biological research; research and development of vaccines and medicines; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical products development; pharmaceutical and biopharmaceutical formulation design and development services, namely development of pharmaceutical and biopharmaceutical preparations and medicines; pre-formulation screening services, namely conducting early evaluations in the field of new pharmaceutical and testing, inspection and research of pharmaceuticals; conducting clinical trials for others for optimisation of pharmaceutical and biopharmaceutical formulations and dosage through clinical testing; development of pharmaceutical and biopharmaceutical preparations and medicines, research and development of vaccines and medicines, product research and development, product development for others, research relating to medicine, namely, medical research, basic and clinical research in the field of pharmacology; consultancy relating to pharmaceutical and biopharmaceutical testing and screening programs in particular testing, inspection and research of pharmaceuticals and biopharmaceuticals; consultancy in the field of pharmacology; clinical pharmacology, namely technical research, testing and consulting in the field of pharmaceutical and biopharmaceutical studies; laboratory research services relating to pharmaceuticals

Owner

• Quotient Sciences Limited, Nottingham, GB

Prosecution history

• 15 Sept 2026 — APPLICATION FILING RECEIPT MAILED
• 15 Sept 2026 — NEW APPLICATION ENTERED